Clinical Trial: A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07044765) titled 'A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study' on June 17.

Brief Summary: To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults after taking the drugs with food (fed state).

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Type2 Diabetes Mellitus

Intervention: DRUG: Comparator 1

Dapagliflozin 10mg + Linagliptin 5mg

DRUG: Comparator 2

Metformin 1000mg

DRUG: Test Drug

Fixed-dose combination tablet (AJU-A53)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AJU Pharm Co.,...